Assembly and remodeling of collagen and elastic fibers in pathophysiology: Proteases have the final cut
Abstract
The extracellular matrix (ECM) provides both architectural integrity and signaling cues to tissues, largely through its fibrous components—collagen and elastin. Collagen fibrils consist of a core of various collagen types associated with several non‐collagenous binding partners and confer tensile strength to tissues, while elastic fibers, composed of cross‐linked elastin on a fibrillin‐rich scaffold, ensure elasticity and resilience. Far from being mere degradative enzymes, proteases are key regulators of both the assembly and turnover of these networks. Metalloproteinases of the BMP1/tolloid‐like, meprin and ADAMTS families orchestrate procollagen maturation, while lysyl oxidases and related enzymes drive covalent cross‐linking of collagen and elastin fibers, also under proteolytic control. Matrix metalloproteinases (MMPs) and cysteine cathepsins further modulate collagen structure and degradation, generating bioactive fragments used as clinical biomarkers. In parallel, ADAMTS and ADAMTS‐like proteases orchestrate fibrillin microfibril organization, fibulin interactions, and the topography of elastogenesis. Elastolytic proteases—including cathepsins K, S, and V, as well as MMP2, MMP7, MMP9, and MMP12—mediate physiological remodeling but also fuel pathological states when dysregulated, releasing elastin‐derived peptides that act as potent signaling matrikines. Genetic or acquired defects in these proteolytic pathways underlie diverse connective tissue diseases such as osteogenesis imperfecta, Ehlers–Danlos, and acromelic dysplasias, as well as fibrosis, emphysema, and vascular aging. This review integrates recent structural, biochemical, and pathological insights into how proteases coordinate collagen and elastin dynamics, highlighting novel therapeutic strategies—including substrate‐ and exosite‐selective inhibitors—to restore ECM homeostasis while minimizing off‐target effects.
Related
- Exercise Improves Dermal Collagen and Elastic Fibers: In Vivo Evidence From Female Volunteers and an Animal Model
- Paracrine Signals from the Tumor Microenvironment Modulate Stem Cell Collagen Interaction and Remodeling, Indicating Early Functional Changes.
- Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression
- P4HA2 mediates hypoxia-induced collagen remodeling to promote tumor progression in head and neck squamous cell carcinoma
- Extracellular matrix collagen remodeling predicts resistance to immune checkpoint blockade in mismatch repair-deficient endometrial cancer
BibTeX
@article{haddou2026assembly,
title = {{Assembly and remodeling of collagen and elastic fibers in pathophysiology: Proteases have the final cut}},
author = {Sabrina Haddou and Alexis David and Oskar Lipinski and Rosa Doñate Puertas and Agathe Maroteaux and Carine Le Goff and Catherine Moali and Fabien Lecaille and Laurent Duca},
journal = {FEBS Journal},
year = {2026},
month = may,
doi = {10.1111/febs.70608},
url = {https://hal.science/hal-05692480v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Assembly and remodeling of collagen and elastic fibers in pathophysiology: Proteases have the final cut
AU - Sabrina Haddou
AU - Alexis David
AU - Oskar Lipinski
AU - Rosa Doñate Puertas
AU - Agathe Maroteaux
AU - Carine Le Goff
AU - Catherine Moali
AU - Fabien Lecaille
AU - Laurent Duca
PY - 2026
DA - 2026/05/29
JO - FEBS Journal
DO - 10.1111/febs.70608
UR - https://hal.science/hal-05692480v1
AB - The extracellular matrix (ECM) provides both architectural integrity and signaling cues to tissues, largely through its fibrous components—collagen and elastin. Collagen fibrils consist of a core of various collagen types associated with several non‐collagenous binding partners and confer tensile strength to tissues, while elastic fibers, composed of cross‐linked elastin on a fibrillin‐rich scaffold, ensure elasticity and resilience. Far from being mere degradative enzymes, proteases are key regulators of both the assembly and turnover of these networks. Metalloproteinases of the BMP1/tolloid‐like, meprin and ADAMTS families orchestrate procollagen maturation, while lysyl oxidases and related enzymes drive covalent cross‐linking of collagen and elastin fibers, also under proteolytic control. Matrix metalloproteinases (MMPs) and cysteine cathepsins further modulate collagen structure and degradation, generating bioactive fragments used as clinical biomarkers. In parallel, ADAMTS and ADAMTS‐like proteases orchestrate fibrillin microfibril organization, fibulin interactions, and the topography of elastogenesis. Elastolytic proteases—including cathepsins K, S, and V, as well as MMP2, MMP7, MMP9, and MMP12—mediate physiological remodeling but also fuel pathological states when dysregulated, releasing elastin‐derived peptides that act as potent signaling matrikines. Genetic or acquired defects in these proteolytic pathways underlie diverse connective tissue diseases such as osteogenesis imperfecta, Ehlers–Danlos, and acromelic dysplasias, as well as fibrosis, emphysema, and vascular aging. This review integrates recent structural, biochemical, and pathological insights into how proteases coordinate collagen and elastin dynamics, highlighting novel therapeutic strategies—including substrate‐ and exosite‐selective inhibitors—to restore ECM homeostasis while minimizing off‐target effects.
SN - 1742-464X
SN - 1742-4658
ER -